Bromocriptine use and myocardial function

Movement Disorders

Volumn 26, Issue 5, 2011, Pages 923-924

  Tan, Louis C S ^a,b   Ng, Kenneth K C ^c   Au, Wing Lok ^a,b   Lee, Raymond K K ^c   Tan, Nigel C K ^b  

^a USA National Parkinson Foundation Centre of Excellence   (United States)

^b NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^c TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; PERGOLIDE;

CARDIOLOGIST; CARDIOVASCULAR RISK; ECHOCARDIOGRAPHY; HEART CONTRACTION; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE FIBROSIS; HEART MUSCLE RELAXATION; HEART VALVE STENOSIS; HISTOPATHOLOGY; HUMAN; LETTER; PARKINSON DISEASE; PRIORITY JOURNAL; PULSE WAVE; TISSUE DOPPLER IMAGING; VALVULAR HEART DISEASE;

BROMOCRIPTINE; DOPAMINE AGONISTS; ECHOCARDIOGRAPHY; FOLLOW-UP STUDIES; HEART; HUMANS; MYOCARDIAL INFARCTION; PARKINSON DISEASE; ULTRASONOGRAPHY;

EID: 79955101539     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23594     Document Type: Letter

References (7)

1. Antonini A, Poewe W. Fibrotic heart-valve reactions to dopamine agonist treatment in Parkinson's disease. Lancet Neurol. 2007; 6: 826-829.
2. Gustafsson BI, Tommeras K, Nodrum I, et al. Long-term serotonin administration induces heart valve disease in rats. Circulation 2005; 111: 1517-1522.
3. Mekontso-Dessap A, Brouri F, Pascal O, et al. Deficiency of 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valulopathy in mice. Circulation. 2006; 113: 81-89.
4. Tan LCS, Ng KKC, Au WL, Lee RKK, Chan YH, Tan NCK. Bromocriptine use and the risk of valvular heart disease. Mov Disord. 2008; 24: 344-349.
5. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification:a report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European association of echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005; 18: 1440-1463.
6. Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr. 2009; 22: 107-133.
7. Rasmussen VG, Poulsen SH, Dupont E, Ostergaard K, Safikhany G, Egeblad H. Ergotamine-derived dopamine agonists and left ventricular function in Parkinson patients: systolic and diastolic function studied by conventional echocardiography, tissue Doppler imaging, and two-dimensional speckle tracking. Eur J Echocardiogr. 2008; 9: 803-808.